Eli Lilly’s $1.4 Trillion Valuation Carries High Expectations
A Reuters Breakingviews commentary characterizes Eli Lilly’s $1.4 trillion valuation as heavily dependent on future hopes.
A Reuters Breakingviews commentary characterizes Eli Lilly’s $1.4 trillion valuation as heavily dependent on future hopes.